Sponsored Content by Daiichi Sankyo
Sponsored
Advertisement
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) cancer survivor Louise (left) and her oncologist, Dr. Ruemu Birhiray (right), built a lasting relationship as they navigated Louise’s diagnosis and relapse. This article is sponsored by MorphoSys and Incyte.
This article is sponsored Astellas Pharma US, Inc.
This article is sponsored by Aadi Bioscience, Inc.
City of Hope sets the bar for treating people, not just diseases.
Care partners need help, too! That’s why this informational booklet was created. It’s full of practical advice from people who have been in your shoes, caring for someone with non-small cell lung cancer.
Learn about the disproportionate impact that the COVID-19 pandemic has on immunocompromised patients with chronic lymphocytic leukemia (CLL), and hear potential solutions from leading CLL experts.
Cindy Cherry, MSN, AGNP-C, and cancer patient Dorothy T. share their experiences with cancer and how they approach chemotherapy treatment.
Learn from survivors! Find out more about care communities, biomarker testing, and how to make the most of every appointment.
Advertisement
Cindy Cherry, MSN, AGNP-C, is an oncology nurse practitioner in Greenville, North Carolina. She treats patients with all types of cancers, including extensive-stage small cell lung cancer (ES-SCLC).
Learn more about the protection of bone marrow and how it may help lower the risk of bone marrow suppression for certain people with small cell lung cancer.
In this episode of the “Cure Talks Cancer” Podcast, Dr. Spira a medical oncologist of the Virginia Cancer Specialists’ (VCS) discusses why KRASG12C is a prolific problem.
Although Stivarga may cause side effects after initial treatment, a dose escalation strategy and the preemptive use of steroid creams may help patients to tolerate the regimen better, while allowing them to capitalize on the agent’s survival benefit.
There are multiple treatment patients for patients with cholangiocarcinoma, here's what you need to know about them.
A clinical research coordinator discusses how patients with cholangiocarcinoma can get involved in clinical trials, such as the phase 3 PROOF trial, as well as what they should know once they are enrolled.
As the treatment landscape for multiple myeloma continues to evolve, it is key for patients to find a specialist in the field, ask questions and learn more about their options.
Dr. Yuliya Linhares discusses cutaneous T-cell lymphoma and the role of a multidisciplinary team of specialists in designing and managing care.
"WellBe was developed to provide meaningful health information on cancer while staying connected to loved ones with our calling and messaging capabilities.”
CLL patient shares his experience with the disease and the importance of aiming to live his life to the fullest despite his diagnosis.
New Initiative Aims to Foster Informed Discussions Between Newly Diagnosed Lung Cancer Patients, Caregivers and Their Healthcare Team
Dr. Jubilee Brown discussed the use of telemedicine and oral treatment options for patients with ovarian cancer, as well as offered advice to ease stress and anxiety throughout the COVID-19 pandemic.
A gastrointestinal malignancy expert discusses the role genomics play in cholangiocarcinoma, as well as how genetic profiling may identify which treatment is best for patients.
“If there’s one thing I can say about cancer treatment, it’s that no one should have to go through it alone,” says one survivor of Hodgkin lymphoma.
Patient Rod Gilmore shares his experience with multiple myeloma and the importance of creating a strategy to manage the disease.
When Emmaly heard the words “you may have cancer,” it was the furthest thing from the mind of this 29-year-old professional.
An expert on clinical and translational research in gastrointestinal malignancies discusses the promising future of targeted therapy in cholangiocarcinoma treatment.
Bladder cancer is the sixth most common cancer in the U.S.
